The analgesic effect of continuous bilateral parasternal infusion of local anaesthetic after open cardiac surgery.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Age 20 to 80 years • ASA 2-3 (American Society of Anesthesiologists) Physcial Status Class 2-3 • Informed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40
Exclusion criteria
Exclusion criteria: • Emergency surgery • Redo sternotomy • Preoperative severe left heart failure • Preoperative respiratory insufficiency • Preoperative advanced kidney failure • Pronounced hepatic disease • Allergy to local anaesthetic • Psychiatric disease or any psychoactive medication • Cognitive disturbance and/or inability to understand written and/or oral instructions • History of chronic pain or chronic pain medication • Failure to be extubated within 4 hours after surgery • Deep hypothermia during surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The study will test the hypothesis that a continuous bilateral parasternal block with lidocaine will decrease postoperative pain after sternotomy for open cardiac surgery. ;Secondary Objective: The study will evaluate whether improved analgesia by a continuous parasternal block will increase postoperative recovery.;Primary end point(s): Cumulated intravenous PCA (Patient Controlled Analgesia) morphine consumption at 72 hours ;Timepoint(s) of evaluation of this end point: After 72 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): • Cumulated NRS (Numeric Rating Scale) score for pain every 8 hours at 72 hours • QoR-15 (Quality of Recovery questionnaire) score at 24,48 and 72 hours as well as 2, 4, 8 and 12 weeks after surgery • NRS at rest at all time points during initial 72 hours • NRS score at rest and in movement at 2, 4, 8 and 12 weeks after surgery • Morphine consumption at 24, 48 and 72 hours • Oxycodon requirement at 2, 4, 8 and 12 weeks after surgery • Cumulated NRS after two deep breaths three times daily, during 72 hours • NRS after two deep breaths three times daily, during 72 hours • NRS at rest and after two deep breaths at 2, 4, 8 and 12 weeks after surgery • Incidence of nausea and/or vomiting at any time during initial 72 hours • Incidence of sedation at any time during initial 72 hours • Incidence of arrhythmia, more than single or solitary coupled supraventricular and ventricular extra beats at any time during initial 72 hours • Spirometry preoperatively, and then postoperatively at the morning after surgery and in the evening from day after surgery until postoperative day 3 • Plasma levels of stress markers and lidocaine 1, 24, 48 and 72 hours postoperatively compared to preoperative values • Day of discharge and discharge time ; Timepoint(s) of evaluation of this end point: Please see E.5.2 | — |
Countries
Sweden
Contacts
Karolinska University Hospital, Dep of Cardiothoracic Anesthesia and Intensive Care